» Articles » PMID: 29094512

Genetics of Type 1 Diabetes

Overview
Publisher Wiley
Date 2017 Nov 3
PMID 29094512
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Type 1 diabetes (T1D) results from immune-mediated loss of pancreatic beta cells leading to insulin deficiency. It is the most common form of diabetes in children, and its incidence is on the rise. This article reviews the current knowledge on the genetics of T1D. In particular, we discuss the influence of HLA and non-HLA genes on T1D risk and disease progression through the preclinical stages of the disease, and the development of genetic scores that can be applied to disease prediction. Racial/ethnic differences, challenges and future directions in the genetics of T1D are also discussed.

Citing Articles

Emerging Immunotherapies for Disease Modification of Type 1 Diabetes.

Foster T, Bruggeman B, Haller M Drugs. 2025; .

PMID: 39873914 DOI: 10.1007/s40265-025-02150-8.


Autoimmune Type 1 Diabetes: An Early Approach Appraisal for Spain by the AGORA Diabetes Collaborative Group.

Gomez-Peralta F, Pines-Corrales P, Santos E, Cuesta M, Gonzalez-Albarran O, Azriel S J Clin Med. 2025; 14(2).

PMID: 39860426 PMC: 11766439. DOI: 10.3390/jcm14020418.


Pre-Type 1 Diabetes in Adolescents and Teens: Screening, Nutritional Interventions, Beta-Cell Preservation, and Psychosocial Impacts.

Sundheim B, Hirani K, Blaschke M, Lemos J, Mittal R J Clin Med. 2025; 14(2).

PMID: 39860389 PMC: 11765808. DOI: 10.3390/jcm14020383.


Health and Racial Disparities in Diabetes Mellitus Prevalence, Management, Policies, and Outcomes in the United States.

Yedjou C, Sims J, Njiki S, Chitoh A, Joseph M, Cherkos A J Community Med Public Health. 2024; 8(3).

PMID: 39697180 PMC: 11654833. DOI: 10.29011/2577-2228.100460.


Genetic Discovery and Risk Prediction for Type 1 Diabetes in Individuals Without High-Risk HLA-DR3/DR4 Haplotypes.

McGrail C, Chiou J, Egamal R, Elgamal R, Luckett A, Oram R Diabetes Care. 2024; 48(2):202-211.

PMID: 39626097 PMC: 11770152. DOI: 10.2337/dc24-1251.


References
1.
Ilonen J, Kiviniemi M, Lempainen J, Simell O, Toppari J, Veijola R . Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity. Pediatr Diabetes. 2016; 17 Suppl 22:8-16. DOI: 10.1111/pedi.12327. View

2.
Morahan G . Insights into type 1 diabetes provided by genetic analyses. Curr Opin Endocrinol Diabetes Obes. 2012; 19(4):263-70. DOI: 10.1097/MED.0b013e328355b7fe. View

3.
Zhao L, Alshiekh S, Zhao M, Carlsson A, Elding Larsson H, Forsander G . Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes. Diabetes. 2016; 65(3):710-8. PMC: 4764147. DOI: 10.2337/db15-1115. View

4.
Skyler J, Greenbaum C, Lachin J, Leschek E, Rafkin-Mervis L, Savage P . Type 1 Diabetes TrialNet--an international collaborative clinical trials network. Ann N Y Acad Sci. 2009; 1150:14-24. PMC: 2918900. DOI: 10.1196/annals.1447.054. View

5.
Lee K, Wucherpfennig K, Wiley D . Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol. 2001; 2(6):501-7. DOI: 10.1038/88694. View